Results for tag: Julie Vose Total Items Found: 29

Challenges in Managing Hodgkin Lymphoma: Focus on Use of Brentuximab Vedotin

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 3/25/2021 3:22:38 PM

B-Cell and T-Cell Non-Hodgkin Lymphomas

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 2/25/2021 2:47:38 PM

ASCO-AACI’s Best Practices in Cancer Clinical Trials Initiative: Streamlining Adverse Events Reporting and Research Community Forum Activities

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 7/20/2017 12:47:05 PM

Julie Vose, MD, MBA, on DLBCL and FL: Expert Commentary on Two Studies

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Julie Vose
UNMC
OPTIMAL>60 study
radiotherapy
diffuse large B-cell lymphoma
immunochemotherapy
geriatric oncology
AHCT
allogeneic hematopoietic cell tr
follicular lymphoma

Created: 6/4/2017 9:12:25 PM

Clifford A. Hudis, MD, and Julie Vose, MD, MBA: A Conversation With ASCO’s CEO

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
ASCO 2017
Clifford Hudis
Julie Vose
UNMC
cancer care
oncology

Created: 6/4/2017 8:54:21 PM

Bruce E. Johnson, MD, and Julie Vose, MD, MBA: A Conversation With ASCO’s 2017–2018 President

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
ASCO 2017
Julie Vose
UNMC
Bruce Johnson
Dana-Farber
ASCO President

Created: 6/4/2017 8:49:42 PM

Julie Vose, MD, MBA, and Anjali Advani, MD, on AML: Results of Two Trials on Vadastuximab Talirine

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Julie Vose
University of Nebraska Medical C
Anjali Advani
Cleveland Clinic
AML
acute myeloid leukemia
vadastuximab talirine
hypomethylating agents
older patients

Created: 12/5/2016 3:01:49 PM

Julie Vose, MD, MBA, and Mhairi Copland, MB, ChB, PhD, on CML: Data From the British DESTINY Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Julie Vose
Mhairi Copland
CML
chronic myeloid leukemia
DESTINY study
University of Nebraska Medical
Paul O'Gorman Leukaemia Research
tyrosine kinase inhibitor
dose decrease

Created: 12/5/2016 2:57:45 PM

Catherine Thieblemont, MD, PhD, and Julie Vose, MD, MBA, on DLBCL: Results From the Lysa Remarc Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Catherine Thieblemont
Hôpital Saint-Louis
INSERM
Julie Vose
University of Nebraska Medical C
DLBCL
diffuse large b cell lymphoma
Lysa Remarc trial
lenalidomide
geriatric patients
R-CHOP

Created: 12/4/2016 6:08:16 PM

Jean M. Connors, MD, and Julie Vose, MD, MBA, on Thrombosis and Anticoagulation: Best of ASH Clinical Data

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Jean Connors
Brigham and Women's Hospital
Julie Vose
University of Nebraska Medical C
thrombosis
anticoagulation
hematologic malignancies

Created: 12/4/2016 2:16:39 PM

James O. Armitage, MD, on Improving Lymphoma Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan-Pacific Lymphoma 2016
Julie Vose
highlights
University of Nebraska
Jim Armitage

Created: 7/21/2016 2:33:55 PM

Julie M. Vose, MD, MBA, on Basket Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
Julie Vose
clinical trials
basket trials
Pan-Pacific Lymphoma 2016
University of Nebraska
genomic

Created: 7/20/2016 2:39:54 PM

Julie M. Vose, MD, MBA, on Highlights of Pan Pacific Lymphoma 2016

Type of Page:TapVideo
Edit This Item
Tags for this item:
University of Nebraska
Julie Vose
highlights
Pan-Pacific Lymphoma 2016

Created: 7/20/2016 11:06:33 AM

Bruce D. Cheson, MD, and Julie M. Vose, MD, MBA, on Staging Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Bruce Cheson
Georgetown University
University of Nebraska
Julie Vose
Pan-Pacific Lymphoma 2016
PET scan
lymphoma
follow-up scans
staging

Created: 7/20/2016 11:01:22 AM

Julie M. Vose MD MBA FASCO on Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
julie m. vose
nivolumab
hodgkin lymphoma
immunotherapy
pd-1 blockade
asco post
cancer

Created: 1/31/2016 9:52:30 AM

Julie M Vose MD MBA FASCO on Ublituximab Plus TGR-1202 in Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
julie m. vose
ublituximab
tgr-1202
lymphoma
hematology
oncology
cancer
asco post

Created: 1/31/2016 9:51:12 AM

Julie M Vose MD MBA FASCO on the AETHERA trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
julie m. vose
aethera trial
brentuximab vedotin
steml cell transplant
hodgkin lymphoma
cancer
oncology
asco post

Created: 1/31/2016 9:47:40 AM

ASCO President-Elect Julie Vose, MD, MBA

Type of Page:TapVideo
Edit This Item
Tags for this item:
Julie Vose
ASCO 2015
patient-centered care
University of Nebraska Medical

Created: 1/31/2016 8:50:36 AM

Can Obinutuzumab Benefit Patients With Rituximab-Refractory Non-Hodgkin Lymphoma?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:22:45 PM

Transplant Now or Later for High-Risk Aggressive Non-Hodgkin Lymphoma?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:17:44 PM

The Power of Laughter

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:03:31 PM

Collective Wisdom: Patient-Centered Care and Research

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 4:54:47 PM

Our Patients Are the True Heroes of Cancer Research

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 4:53:57 PM

The Importance of Supporting the Role of Women Leaders in Oncology

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 4:52:12 PM

Julie Vose, MD, MBA, and John F. Gerecitano, MD, PhD, on Venetoclax for NHL

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
University of Nebraska Medical C
John Gerecitano
Memorial Sloan Kettering
NHL
non-Hodgkin lymphoma
venetoclax
monotherapy
relapsed/refractory

Created: 12/24/2015 12:25:03 PM

Julie Vose, MD, MBA, and David Straus, MD, on Hodgkin Lymphoma Study Results: CALGB/Alliance 50604

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
David Straus
University of Nebraska Medical C
Memorial Sloan Kettering
CALGB/Alliance 50604
US Intergroup
response-adapted chemotherapy
radiation therapy
PET
non-bulky
stage I
stage II
HL
Hodgkin lymphoma

Created: 12/24/2015 12:08:11 PM

Julie Vose, MD, MBA, and Rafat Abonour, MD, on Multiple Myeloma: The Path to a Cure

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
University of Nebraska Medical C
Rafat Abonour
Indiana University Simon Cancer
multiple myeloma
disease heterogeneity
myeloma clones

Created: 12/24/2015 12:07:35 PM

Julie Vose, MD, MBA, on ALL Overall Survival: Academic vs Nonacademic Hospitals

Type of Page:TapVideo
Edit This Item
Tags for this item:

Created: 12/24/2015 12:05:26 PM

Julie Vose, MD, MBA, and Cameron J. Turtle, MBBS, PhD, on B-Cell NHL and CLL: Clinical Trial Results on T-Cell Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
University of Nebraska Medical C
Cameron Turtle
Fred Hutch Cancer Center
anti-CD19
B-cell non-Hodgkin lymphoma
NHL
CLL
chronic lymphocytic leukemia
T-cell therapy
chimeric antigen receptor

Created: 12/24/2015 12:02:28 PM
Order By Item Count
Order Alphabetically